Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 2.0 Contact Hours.
Not an official event of the 2017 ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the Conquer Cancer Foundation.
This activity is supported by an educational grant from AstraZeneca.
Evolving Applications of Immuno-Oncology Strategies: New Approaches, New Combinations, and New Ways to Care for Lung, Head and Neck, and Bladder Cancers is a live symposium that will be held adjunct to the annual oncology meeting in Chicago. The emergence of immuno-oncology strategies to treat cancer has transformed the way clinicians think about solid tumor management. Among these tumors, lung cancer, head and neck cancer, and bladder cancer have become a major focus of investigational efforts in immuno-oncology research due to both substantial unmet clinical needs and evidence demonstrating the clinical potential of these approaches. In addition to single-agent immunotherapy, the use of novel immuno-oncology combinations is generating interest, and rational clinical trial designs are combining immunotherapy with a wide range of partner therapeutics, with the goal of inducing profound and durable responses. Further, the speed at which information continues to emerge in the immuno-oncology space is creating practice and/or educational gaps for oncology clinicians who strive to maintain state-of-the-art care for their patients. To address these educational needs, this symposium also will feature internationally renowned experts in immuno-oncology who will discuss key emerging clinical data sets, the role of evolving biomarkers, and how to safely apply immunotherapy to a wide variety of malignancies.
Key topics to be addressed by faculty include:
The symposium will be held at the Hilton Chicago on June 3, 2017, from 7:00 PM-9:00 PM. Please join us learn about the latest immuno-oncology approaches that you can apply in your clinical practice. This is a symposium not to be missed!
This educational activity is directed toward medical oncologists. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of cancer are also invited to participate.
Upon completion of this activity, participants will be better prepared to:
Roy S. Herbst, MD, PhD
Ensign Professor of Medicine (Medical Oncology)
Professor of Pharmacology
Chief of Medical Oncology
Associate Director for Translational Research
Yale Cancer Center, Smilow Cancer Hospital
New Haven, CT
ONS: PER Forum™: Nursing Opportunities to Improve Outcomes With the Advent of PARP Inhibitors in the Care of Women’s Cancers
May 17, 2018
ONS: Working Group for Changing Standards in EGFR-Mutated Lung Cancers: Real-World Applications of the Evidence for Nurses
May 17, 2018
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of Cancers
May 30, 2018
May 31, 2018
May 31, 2018